Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-033483
Filing Date
2022-10-12
Accepted
2022-10-12 16:14:01
Documents
2
Period of Report
2022-10-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1628
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4585
  Complete submission text file 0000899243-22-033483.txt   7596
Mailing Address C/O ASYA ALEXANDROVICH ONE FINANCIAL CENTER BOSTON MA 021111
Business Address
MURPHY JAMES B (Reporting) CIK: 0001282721 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40030 | Film No.: 221306994

Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215 617-370-8701
Decibel Therapeutics, Inc. (Issuer) CIK: 0001656536 (see all company filings)

EIN.: 464198709 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations